Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-130-8 | CAS number: 93777-98-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based on the available information from the key acute oral toxicity study the LD50 for 1,1-dimethyl-N,N'-bis(1-methylpropyl)silanediamine was concluded to be 907.45 mg/kg bw. The study was conducted according to OECD test guideline 401 and in compliance with GLP (Pharmakon, 1993).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21/12/1992 to 18/03/1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (now deleted)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Ico: OFA.SD. (IOPS Caw)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa-Credo, France
- Age at study initiation: 5 to 7 weeks old
- Weight at study initiation: males 130-230 g and females 120-180 g
- Fasting period before study: 15-20 hours before treatment
- Housing: in an air conditioned building. Animals kept in group of 5 of the same sex in type MI polycarbonate cages.
- Diet (e.g. ad libitum): pelleted complete diet ad libitum
- Water (e.g. ad libitum): filtered mains drinking water ad libitum
- Acclimation period: 5 days minimum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70% R.H.
- Air changes (per hr): minimum 8 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg
- Doses:
- 20-30 males and females were separated in 4 groups and treated with 567 mg/kg, 689 mg/kg, 826 mg/kg and 1004 mg/kg.
- No. of animals per sex per dose:
- 20 to 30 males and 20 to 30 females
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals observed 15 minutes after the administration, then at 1, 2 and 4 hours, then daily for the 14-day study. The body weight was measured a day before the treatment, immediately before the treatment and on day 8 and 15, and on the day of the death.
- Necropsy of survivors performed: at day 15 surviving animals were killed by overdosing with carbon dioxide and necropsied. Necropsy was performed to the dead animals during the study. Examination was performed of the external surface, all orifices, the thoracic, abdominal and pelvic cavities and viscera.
- Other examinations performed: clinical signs, body weight, organ weights, histopathology, other: animals surviving 24 hours or more after administration of the testing article, organs with macroscopic lesions will be kept in fixative until agreement reached to be examined by a pathologist. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 907.46 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Bliss' method
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 907.45 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Litchfield and Wilcoxon's method
- Mortality:
- The group treated with 689 mg/kg of the tested article showed 10 % mortality. The ones treated with 826 mg/kg - 30% mortality and those treated with 1004 mg/kg - 100 % mortality.
- Clinical signs:
- Subdued behaviour for the first 3 days of the study was observed in all the groups of animals. Abdominal distension was observed in groups treated with 689 mg/kg, 826 mg/kg and 1004 mg/kg from day 7 until day 15 from the study.
- Body weight:
- A slight decrease was observed in the body weight of the treated males when compared to the control group, while there was no significant change in the body weight of females.
- Gross pathology:
- Adhesion was observed between the stomach and the abdominal wall, liver and the abdominal wall, liver and the stomach, stomach and the spleen in all surviving animals. The rats that dies before the end of the observation period had stomachs distended by a reddish liquid and very congested intestines.
- Other findings:
- - Other observations: Some of the dead individual before the end of the observation period had congested stomach, autolysed alimentary canal and pale liver.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- In an acute oral toxicity study conducted to the now deleted OECD 401 and to GLP, the LD50 is 907.45 mg/kg for 1,1-dimethyl-N,N'-bis(1-methylpropyl)silanediamine.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 907.45 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the key study for acute oral toxicity, gavage administration of test substance at dose levels of 567, 689, 826 and 1004 mg/kg bw to groups of five male and five female rats resulted in mortality levels of 0, 10, 30 and 100% respectively (Pharmakon, 1993). Mortalities occurred from Day 1 (4 hours) to day 3, depending on the dose. Clinical signs observed included subdued behaviour for the first 3 days of the study in all the groups of animals. Abdominal distension was observed in groups treated with 689, 826 and 1004 mg/kg bw from day 7 until day 15 from the study.
At necropsy, the animals that survived until study completion showed congested areas in the stomach and intestines. The animals that died during the study showed adhesion between the liver, abdominal wall, stomach, spleen and intestines.
The LD50 was calculated to be 907.45 (95% confidence interval 797.35<LD50<1032.74).
Justification for classification or non-classification
Based on the available data, 1,1-dimethyl-N,N'-bis(1-methylpropyl)silanediamine is classified for Acute Oral Toxicity, Category IV, 'H302: Harmful if swallowed' according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.